Gene · 10112
Papers1,613
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,613
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unveiling the Potential Role of Hesperetin and Emodin as a Combination Therapy to Inhibit the Pancreatic Cancer Progression against the C-Met Gene. | Protein Pept Lett | 2025 | 40129158 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis reveals key hub genes linked to prognosis in multiple myeloma with drug resistance. | Medicine (Baltimore) | 2025 | 40068082 | PubTator, text mining | PubMed |
| The Hypoxia-Associated High-Risk Cell Subpopulation Distinctly Enhances the Progression of Glioma. | Adv Sci (Weinh) | 2025 | 40047299 | PubTator, text mining | PubMed |
| Potential Biomarkers and Therapeutic Targets in Hepatitis B Virus-related Acute Liver Failure: Interplay of the Ferroptosis, Autophagy and Immune Responses. | Int J Med Sci | 2025 | 39991755 | PubTator, text mining | PubMed |
| Identification of key biomarkers in breast cancer based on bioinformatics analysis and experimental verification. | J Egypt Natl Canc Inst | 2025 | 39988630 | PubTator, text mining | PubMed |
| A novel golgi related genes based correlation prognostic index can better predict the prognosis of glioma and responses to immunotherapy. | Discov Oncol | 2025 | 39976877 | PubTator, text mining | PubMed |
| BRD4 interacting genes as prognostic biomarkers in hepatocellular carcinoma for optimized treatment strategies. | Sci Rep | 2025 | 39955326 | PubTator, text mining | PubMed |
| Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment. | Curr Genomics | 2025 | 39911278 | PubTator, text mining | PubMed |
| The miRNA-mRNA Regulatory Network in Human Hepatocellular Carcinoma by Transcriptomic Analysis From GEO. | Cancer Rep (Hoboken) | 2025 | 39764737 | PubTator, text mining | PubMed |
| A KIF20A-based thermosensitive hydrogel vaccine effectively potentiates immune checkpoint blockade therapy for hepatocellular carcinoma. | NPJ Vaccines | 2025 | 39753573 | PubTator, text mining | PubMed |
| CBX3 contributes to pancreatic adenocarcinoma progression via promoting KIF20A expression. | Cytotechnology | 2025 | 39735331 | PubTator, text mining | PubMed |
| Molecular and mechanical mechanisms of animal cell abscission. | FEBS Lett | 2025 | 39324548 | PubTator, text mining | PubMed |
| Gene Expression Changes Associated With Recurrence After Gross Total Resection of Newly Diagnosed World Health Organization Grade 1 Meningioma. | Neurosurgery | 2025 | 39101743 | PubTator, text mining | PubMed |
| Identification of MAD2L1 and BUB1B as Potential Biomarkers Associated with Progression and Prognosis of Ovarian Cancer. | Biochem Genet | 2025 | 38683465 | PubTator, text mining | PubMed |
| Therapeutic target genes and regulatory networks of gallic acid in cervical cancer. | Front Genet | 2024 | 39902297 | PubTator, text mining | PubMed |
| Identification and validation of KIF20A for predicting prognosis and treatment outcomes in patients with breast cancer. | Sci Rep | 2024 | 39733078 | PubTator, text mining | PubMed |
| Role of KIF20A Depletion in Inhibiting Ovarian Cancer Progression: Insights From PTEN and M2 Macrophage Polarization. | Discov Med | 2024 | 39726317 | PubTator, text mining | PubMed |
| A novel risk model consisting of nine platelet-related gene signatures for predicting prognosis, immune features and drug sensitivity in glioma. | Hereditas | 2024 | 39707577 | PubTator, text mining | PubMed |
| KIF20A activated by transcription factor GATA2 promotes cell growth in hepatitis B virus-related hepatocellular carcinoma. | Front Cell Infect Microbiol | 2024 | 39624268 | PubTator, text mining | PubMed |
| Identification and validation of a novel prognostic signature and key genes related to development of anaplastic thyroid carcinoma. | Discov Oncol | 2024 | 39562412 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10112/papers?page=6